Literature DB >> 26740270

Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?

Timothy Ross Elliott1, Tiffany Symes2, George Kannourakis3, Peter Angus4.   

Abstract

Liver injury due to idiosyncratic drug reactions can be difficult to diagnose and may lead to acute liver failure (ALF), which has a high mortality rate. N-acetylcysteine (NAC) is effective treatment for paracetamol toxicity, but its role in non-paracetamol drug-induced ALF is controversial. We report on the use of a validated bedside tool to establish causality for drug-induced liver injury (DILI) and describe the first case of resolution of norfloxacin-induced ALF after NAC therapy. NAC is easy to administer and generally has a good safety profile. We discuss the evidence to support the use of NAC in ALF secondary to DILI and possibilities for further clinical research in this field. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740270      PMCID: PMC4716361          DOI: 10.1136/bcr-2015-213189

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis.

Authors:  E Björnsson; R Olsson; H Remotti
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Norfloxacin-induced hepatotoxicity.

Authors:  A López-Navidad; P Domingo; J Cadafalch; J Farrerons
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

Review 3.  Norfloxacin-induced cholestatic jaundice.

Authors:  M I Lucena; R J Andrade; H Sanchez-Martinez; J M Perez-Serrano; A Gomez-Outes
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

4.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

5.  N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Authors:  Chantal Bémeur; Javier Vaquero; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

6.  Norfloxacin-induced hepatitis.

Authors:  P Davoren; K Mainstone
Journal:  Med J Aust       Date:  1993-09-20       Impact factor: 7.738

Review 7.  Use of acetylcysteine for non-acetaminophen-induced acute liver failure.

Authors:  Ibrahim Sales; Amy L Dzierba; Pamela L Smithburger; Deanna Rowe; Sandra L Kane-Gill
Journal:  Ann Hepatol       Date:  2013 Jan-Feb       Impact factor: 2.400

8.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

Review 9.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27

10.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.

Authors:  William M Lee; Linda S Hynan; Lorenzo Rossaro; Robert J Fontana; R Todd Stravitz; Anne M Larson; Timothy J Davern; Natalie G Murray; Timothy McCashland; Joan S Reisch; Patricia R Robuck
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

View more
  3 in total

Review 1.  N-acetylcysteine for non-acetaminophen induced acute liver failure: A review.

Authors:  Shirley Xue Jiang; Trana Hussaini; Eric M Yoshida
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

2.  S-allyl-L-cysteine protects hepatocytes from indomethacin-induced apoptosis by attenuating endoplasmic reticulum stress.

Authors:  Peng Chen; Chen Chen; Mingdao Hu; Rui Cui; Feng Liu; Henghai Yu; Yuling Ren
Journal:  FEBS Open Bio       Date:  2020-08-16       Impact factor: 2.693

Review 3.  Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review.

Authors:  Meng Li; Qiong Luo; Yanyan Tao; Xin Sun; Chenghai Liu
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.